Silvergate Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
Plaintiff: Silvergate Pharmaceuticals, Inc.
Defendant: Alkem Laboratories Ltd.
Case Number: 1:2019cv02100
Filed: November 5, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Leonard P Stark
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 1
Jury Demanded By: None
Docket Report

This docket was last retrieved on February 10, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 15, 2019 Opinion or Order SO ORDERED, re (11 in 1:19-cv-01067-LPS, 6 in 1:19-cv-02100-LPS) MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson and Yan-Xin Li filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 11/15/19. Associated Cases: 1:19-cv-01067-LPS, 1:19-cv-02100-LPS (ntl)
November 14, 2019 Opinion or Order Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson and Yan-Xin Li - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
November 13, 2019 Opinion or Order Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
November 6, 2019 Opinion or Order Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Ltd. on 11/6/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam)
November 5, 2019 Opinion or Order Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma, Inc. for Silvergate Pharmaceuticals, Inc. filed by Silvergate Pharmaceuticals, Inc. (sam)
November 5, 2019 Opinion or Order Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,008 B1 ;9,808,442 B2 ;10,039,745 B2 ;10,154,987 B2. (sam)
November 5, 2019 Opinion or Order Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 25, 2019. Date of Expiration of Patent: March 25, 2036.Thirty Month Stay Deadline: 03/25/2022. (sam)
November 5, 2019 Opinion or Order Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
November 5, 2019 Opinion or Order Filing 1 COMPLAINT for patent infringement filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2771746.) - filed by Silvergate Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(sam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Silvergate Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Silvergate Pharmaceuticals, Inc.
Represented By: Jack B. Blumenfeld
Represented By: Megan Elizabeth Dellinger
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?